The growth hormone-insulin like growth factor axis revisited: Lessons from IGF-1 and IGF-1 receptor gene targeting

Shoshana Yakar, Hyunsook Kim, Hong Zhao, Yuka Toyoshima, Patricia Pennisi, Oksana Gavrilova, Derek LeRoith

Research output: Contribution to journalArticle

Abstract

We have created a liver-specific igf1 gene-deletion mouse model (LID) with markedly reduced circulating IGF-I levels. They demonstrate that while they have normal growth and development they develop insulin resistance secondary to the elevation of circulating growth hormone. When mated with an acid-labile subunit (ALS) gene-deleted mouse they also show osteopenia suggesting that circulating IGF-I levels play a significant role in bone formation. In a separate transgenic mouse we created a model of severe insulin resistance and type 2 diabetes by the overexpression of a dominant-negative IGF-I receptor in skeletal muscle. In this model we show that lipotoxicity plays a major role in the progression of the disease and is affected by treatment with a fibrate, which reverses the insulin resistance and diabetic state. These models are therefore very useful in studying human physiology and disease states.

Original languageEnglish (US)
Pages (from-to)251-254
Number of pages4
JournalPediatric Nephrology
Volume20
Issue number3 SPEC. ISS.
DOIs
StatePublished - Mar 2005

Fingerprint

IGF Type 1 Receptor
Gene Targeting
Somatomedins
Insulin-Like Growth Factor I
Growth Hormone
Insulin Resistance
Fibric Acids
Metabolic Bone Diseases
Gene Deletion
Growth and Development
Osteogenesis
Type 2 Diabetes Mellitus
Transgenic Mice
Disease Progression
Skeletal Muscle
Acids
Liver
Genes

Keywords

  • Insulin-like growth factor-1
  • Insulin-like growth factor-1 receptor
  • Lipotoxicity
  • Liver-specific igf1 deletion
  • Mouse model
  • Transgenic overexpression
  • Type2 diabetes

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

The growth hormone-insulin like growth factor axis revisited : Lessons from IGF-1 and IGF-1 receptor gene targeting. / Yakar, Shoshana; Kim, Hyunsook; Zhao, Hong; Toyoshima, Yuka; Pennisi, Patricia; Gavrilova, Oksana; LeRoith, Derek.

In: Pediatric Nephrology, Vol. 20, No. 3 SPEC. ISS., 03.2005, p. 251-254.

Research output: Contribution to journalArticle

Yakar, S, Kim, H, Zhao, H, Toyoshima, Y, Pennisi, P, Gavrilova, O & LeRoith, D 2005, 'The growth hormone-insulin like growth factor axis revisited: Lessons from IGF-1 and IGF-1 receptor gene targeting', Pediatric Nephrology, vol. 20, no. 3 SPEC. ISS., pp. 251-254. https://doi.org/10.1007/s00467-004-1613-y
Yakar, Shoshana ; Kim, Hyunsook ; Zhao, Hong ; Toyoshima, Yuka ; Pennisi, Patricia ; Gavrilova, Oksana ; LeRoith, Derek. / The growth hormone-insulin like growth factor axis revisited : Lessons from IGF-1 and IGF-1 receptor gene targeting. In: Pediatric Nephrology. 2005 ; Vol. 20, No. 3 SPEC. ISS. pp. 251-254.
@article{370ea468d96a4c46a8ceba6190c51c4c,
title = "The growth hormone-insulin like growth factor axis revisited: Lessons from IGF-1 and IGF-1 receptor gene targeting",
abstract = "We have created a liver-specific igf1 gene-deletion mouse model (LID) with markedly reduced circulating IGF-I levels. They demonstrate that while they have normal growth and development they develop insulin resistance secondary to the elevation of circulating growth hormone. When mated with an acid-labile subunit (ALS) gene-deleted mouse they also show osteopenia suggesting that circulating IGF-I levels play a significant role in bone formation. In a separate transgenic mouse we created a model of severe insulin resistance and type 2 diabetes by the overexpression of a dominant-negative IGF-I receptor in skeletal muscle. In this model we show that lipotoxicity plays a major role in the progression of the disease and is affected by treatment with a fibrate, which reverses the insulin resistance and diabetic state. These models are therefore very useful in studying human physiology and disease states.",
keywords = "Insulin-like growth factor-1, Insulin-like growth factor-1 receptor, Lipotoxicity, Liver-specific igf1 deletion, Mouse model, Transgenic overexpression, Type2 diabetes",
author = "Shoshana Yakar and Hyunsook Kim and Hong Zhao and Yuka Toyoshima and Patricia Pennisi and Oksana Gavrilova and Derek LeRoith",
year = "2005",
month = "3",
doi = "10.1007/s00467-004-1613-y",
language = "English (US)",
volume = "20",
pages = "251--254",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "3 SPEC. ISS.",

}

TY - JOUR

T1 - The growth hormone-insulin like growth factor axis revisited

T2 - Lessons from IGF-1 and IGF-1 receptor gene targeting

AU - Yakar, Shoshana

AU - Kim, Hyunsook

AU - Zhao, Hong

AU - Toyoshima, Yuka

AU - Pennisi, Patricia

AU - Gavrilova, Oksana

AU - LeRoith, Derek

PY - 2005/3

Y1 - 2005/3

N2 - We have created a liver-specific igf1 gene-deletion mouse model (LID) with markedly reduced circulating IGF-I levels. They demonstrate that while they have normal growth and development they develop insulin resistance secondary to the elevation of circulating growth hormone. When mated with an acid-labile subunit (ALS) gene-deleted mouse they also show osteopenia suggesting that circulating IGF-I levels play a significant role in bone formation. In a separate transgenic mouse we created a model of severe insulin resistance and type 2 diabetes by the overexpression of a dominant-negative IGF-I receptor in skeletal muscle. In this model we show that lipotoxicity plays a major role in the progression of the disease and is affected by treatment with a fibrate, which reverses the insulin resistance and diabetic state. These models are therefore very useful in studying human physiology and disease states.

AB - We have created a liver-specific igf1 gene-deletion mouse model (LID) with markedly reduced circulating IGF-I levels. They demonstrate that while they have normal growth and development they develop insulin resistance secondary to the elevation of circulating growth hormone. When mated with an acid-labile subunit (ALS) gene-deleted mouse they also show osteopenia suggesting that circulating IGF-I levels play a significant role in bone formation. In a separate transgenic mouse we created a model of severe insulin resistance and type 2 diabetes by the overexpression of a dominant-negative IGF-I receptor in skeletal muscle. In this model we show that lipotoxicity plays a major role in the progression of the disease and is affected by treatment with a fibrate, which reverses the insulin resistance and diabetic state. These models are therefore very useful in studying human physiology and disease states.

KW - Insulin-like growth factor-1

KW - Insulin-like growth factor-1 receptor

KW - Lipotoxicity

KW - Liver-specific igf1 deletion

KW - Mouse model

KW - Transgenic overexpression

KW - Type2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=14644408079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644408079&partnerID=8YFLogxK

U2 - 10.1007/s00467-004-1613-y

DO - 10.1007/s00467-004-1613-y

M3 - Article

VL - 20

SP - 251

EP - 254

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 3 SPEC. ISS.

ER -